{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:52:33Z","timestamp":1752670353487,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41397-018-0023-7","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T10:48:07Z","timestamp":1525171687000},"page":"565-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7558-7323","authenticated-orcid":false,"given":"F\u00e9lix Javier","family":"Jim\u00e9nez-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gara","family":"Esguevillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hortensia","family":"Alonso-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Zurdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Turp\u00edn-Fenoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Mill\u00e1n-Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Adeva-Bartolom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Cubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Navacerrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Amo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Rojo-Sebasti\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lluisa","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"D\u00edez-Fair\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Francisco","family":"Plaza-Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Pilo-de-la-Fuente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Arroyo-Solera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Garc\u00eda-Albea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A. G.","family":"Ag\u00fandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"issue":"17","key":"23_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.smrv.2017.08.002","volume":"39","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2018","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JAG. Genetics of restless legs syndrome: an update. Sleep Med Rev. 2018;39:108\u201321.","journal-title":"Sleep Med Rev"},{"key":"23_CR2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1474-4422(17)30327-7","volume":"16","author":"B Schormair","year":"2017","unstructured":"Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, P\u00fctz B, et al. Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurol. 2017;16:898\u2013907.","journal-title":"Lancet Neurol"},{"key":"23_CR3","doi-asserted-by":"publisher","first-page":"e1448","DOI":"10.1097\/MD.0000000000001448","volume":"94","author":"E Garc\u00eda-Mart\u00edn","year":"2015","unstructured":"Garc\u00eda-Mart\u00edn E, Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Mart\u00ednez C, Zurdo M, Turp\u00edn-Fenoll L, et al. Heme oxygenase-1 and 2 common genetic variants and risk for restless Legs Syndrome. Medicine 2015;94:e1448.","journal-title":"Medicine"},{"key":"23_CR4","doi-asserted-by":"publisher","first-page":"e2125","DOI":"10.1097\/MD.0000000000002125","volume":"94","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2015","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Garc\u00eda-Mart\u00edn E, Alonso-Navarro H, Mart\u00ednez C, Zurdo M, Turp\u00edn-Fenoll L, et al. Association between vitamin D receptor rs731236 (Taq1) polymorphism and risk for restless Legs Syndrome in the Spanish Caucasian Population. Medicine. 2015;94:e2125.","journal-title":"Medicine"},{"key":"23_CR5","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, G\u00f3mez-Tabales J, Alonso-Navarro H, Zurdo M, Turp\u00edn-Fenoll L, Mill\u00e1n-Pascual J, et al. Association between the rs1229984 polymorphism in the alcohol dehydrogenase 1B gene and risk for restless Legs Syndrome. Sleep. 2017;40. https:\/\/doi.org\/10.1093\/sleep\/zsx174 .","DOI":"10.1093\/sleep\/zsx174"},{"key":"23_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.17925\/ENR.2015.10.01.35","volume":"10","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2015","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JAG. Neurochemistry of idiopathic restless legs syndrome. Eur Neurol Rev. 2015;10:35\u201344. http:\/\/www.touchneurology.com\/articles\/neurochemistry-idiopathic-restless-legs-syndrome","journal-title":"Eur Neurol Rev"},{"key":"23_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.17925\/ENR.2015.10.01.45","volume":"10","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2015","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JAG. Treatment options for idiopathic restless legs syndrome. Eur Neurol Rev. 2015;10:45\u201355. http:\/\/www.touchneurology.com\/articles\/treatment-options-idiopathic-restless-legs-syndrome","journal-title":"Eur Neurol Rev"},{"key":"23_CR8","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.sleep.2014.05.019","volume":"15","author":"JW Winkelman","year":"2014","unstructured":"Winkelman JW, Schoerning L, Platt S, Jensen JE. Restless legs syndrome and central nervous system gamma-aminobutyric acid: preliminary associations with periodic limb movements in sleep and restless leg syndrome symptom severity. Sleep Med. 2014;15:1225\u201330.","journal-title":"Sleep Med"},{"key":"23_CR9","unstructured":"IUPHAR DATABASE. Nomenclature of ligand-gates ion channels. Available at http:\/\/www.iuphar-db.org\/LGIICNomenclature.jsp ."},{"key":"23_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/pr.108.00505","volume":"60","author":"RW Olsen","year":"2008","unstructured":"Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update Pharmacol Rev. 2008;60:243\u201360.","journal-title":"Update Pharmacol Rev"},{"key":"23_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","volume":"4","author":"RP Allen","year":"2003","unstructured":"Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless Legs Syndrome diagnosis and epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology work shop at the National Institute of Health. Sleep Med. 2003;4:101\u201319.","journal-title":"Sleep Med"},{"key":"23_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","volume":"15","author":"RP Allen","year":"2014","unstructured":"Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW. et al.International Restless Legs Syndrome Study Group 2014 Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria - history, rationale, description, and significance. Sleep Med. 2014;15:860\u201373.","journal-title":"Sleep Med"},{"key":"23_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00702-012-0897-5","volume":"120","author":"A Roco","year":"2013","unstructured":"Roco A, Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Mart\u00ednez C, Zurdo M, Turp\u00edn-Fenoll L, et al. MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome. J Neural Transm. 2013;120:463\u20137.","journal-title":"J Neural Transm"},{"key":"23_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.sleep.2012.11.009","volume":"14","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2013","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Mart\u00ednez C, Zurdo M, Turp\u00edn-Fenoll L, Mill\u00e1n J, et al. Dopamine Receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome. Sleep Med. 2013;14:382\u20134.","journal-title":"Sleep Med"},{"key":"23_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.sleep.2013.08.800","volume":"15","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2014","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Mart\u00ednez C, Zurdo M, Turp\u00edn-Fenoll L, Mill\u00e1n J, et al. The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome. Sleep Med. 2014;15:266\u20138.","journal-title":"Sleep Med"},{"key":"23_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00702-014-1322-z","volume":"122","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2015","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Mart\u00ednez C, Zurdo M, Turp\u00edn-Fenoll L, Mill\u00e1n J, et al. Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome. J Neural Transm. 2015;122:819\u201323.","journal-title":"J Neural Transm"},{"key":"23_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00702-016-1645-z","volume":"124","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2017","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Garc\u00eda-Mart\u00edn E, Alonso-Navarro H, Mart\u00ednez C, Zurdo M, Turp\u00edn-Fenoll L, et al. Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl- transferase (HNMT) gene and risk for restless legs syndrome. J Neural Transm. 2017;124:285\u2013291.","journal-title":"J Neural Transm"},{"key":"23_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","volume":"4","author":"AS Walters","year":"2003","unstructured":"Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121\u201332.","journal-title":"Sleep Med"},{"key":"23_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"1","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B. 1995;1:289\u2013300.","journal-title":"J Roy Stat Soc Ser B"},{"key":"23_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1046\/j.0306-5251.2001.01510.x","volume":"52","author":"AK Daly","year":"2001","unstructured":"Daly AK, Day CP. Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol. 2001;52:489\u201399.","journal-title":"Br J Clin Pharmacol"},{"key":"23_CR22","first-page":"59","volume":"10","author":"S P\u00e9rtegas D\u00edaz","year":"2003","unstructured":"P\u00e9rtegas D\u00edaz S, Pita Fern\u00e1ndez S. C\u00e1lculo del poder estad\u00edstico de un estudio. Cad Aten Prima. 2003;10:59\u201363.","journal-title":"Cad Aten Prima"},{"key":"23_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","volume":"309","author":"DG Altman","year":"1994","unstructured":"Altman DG, Bland JM. Diagnostic tests 2: Predictive values. BMJ. 1994;309:102.","journal-title":"BMJ"},{"key":"23_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-71","volume":"10","author":"C Mart\u00ednez","year":"2010","unstructured":"Mart\u00ednez C, Molina JA, Alonso-Navarro H, Jim\u00e9nez-Jim\u00e9nez FJ, Ag\u00fandez JA, Garc\u00eda-Mart\u00edn E. Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol. 2010;10:71.","journal-title":"BMC Neurol"},{"key":"23_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fncel.2018.00010","volume":"12","author":"E Garc\u00eda Mart\u00edn","year":"2018","unstructured":"Garc\u00eda Mart\u00edn E, Ramos MI, Cornejo-Garc\u00eda JA, Galv\u00e1n S, Perkins JR, Rodr\u00edguez-Santos L, et al. Missense gamma-aminobutyric acid receptor polymorphisms are associated with reaction time, motor time, and ethanol effects in vivo. Front Cell Neurosci. 2018;12:10. https:\/\/doi.org\/10.3389\/fncel.2018.00010","journal-title":"Front Cell Neurosci"},{"key":"23_CR26","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1212\/NXI.0000000000000154","volume":"2","author":"MF Bustamante","year":"2015","unstructured":"Bustamante MF, Morcillo-Su\u00e1rez C, Malhotra S, Rio J, Leyva L, Fern\u00e1ndez O, et al. Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-\u03b2. Neurol Neuroimmunol Neuroinflamm. 2015;2:e154.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"23_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1360-0443.2008.02236.x","volume":"103","author":"A Agrawal","year":"2008","unstructured":"Agrawal A, Pergadia ML, Saccone SF, Hinrichs AL, Lessov-Schlaggar CN, Saccone NL, et al. Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study. Addiction. 2008;103:1027\u201338.","journal-title":"Addiction"},{"key":"23_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00415-010-5708-z","volume":"258","author":"E Garc\u00eda-Mart\u00edn","year":"2011","unstructured":"Garc\u00eda-Mart\u00edn E, Mart\u00ednez C, Alonso-Navarro H, Benito-Le\u00f3n J, Lorenzo-Betancor O, Pastor P, et al. Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. J Neurol. 2011;258:203\u201311.","journal-title":"J Neurol"},{"key":"23_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/FPC.0b013e328345bec0","volume":"21","author":"E Garc\u00eda-Mart\u00edn","year":"2011","unstructured":"Garc\u00eda-Mart\u00edn E, Mart\u00ednez C, Alonso-Navarro H, Benito-Le\u00f3n J, Lorenzo-Betancor O, Pastor P, et al. Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor. Pharm Genom. 2011;21:436\u20139.","journal-title":"Pharm Genom"},{"key":"23_CR30","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/head.13122","volume":"57","author":"E Garc\u00eda Mart\u00edn","year":"2016","unstructured":"Garc\u00eda Mart\u00edn E, Mart\u00ednez C, Serrador M, Alonso-Navarro H, Navacerrada F, Esguevillas G, et al. Gamma-aminobutyric acid (GABA) receptors rho (GABRR) gene polymorphisms and risk for migraine. Headache. 2016;57:1118\u201335.","journal-title":"Headache"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41397-018-0023-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-018-0023-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-018-0023-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T11:59:15Z","timestamp":1720267155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-018-0023-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1038\/s41397-018-0023-7","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"type":"print","value":"1470-269X"},{"type":"electronic","value":"1473-1150"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"23 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}